---
title: "daratumumab"
slug: "daratumumab"
date: "2023-07-21"
enableToc: false
tags:
  - building
---

> [!info]
>
> 🌱 來自: [[treatment of amyloidosis]]

# daratumumab

- CD38 蛋白結合的 IgG1κ 人類單株抗體(mAb)
- [Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM](https://www-nejm-org.autorpa.kfsyscc.org/doi/full/10.1056/NEJMoa2028631)
  - Among patients with newly diagnosed AL amyloidosis, the addition of daratumumab to bortezomib, cyclophosphamide, and dexamethasone was associated with higher frequencies of hematologic complete response and survival free from major organ deterioration or hematologic progression.
  - 在新診斷的 → AL 澱粉樣變性患者中，在硼替佐米、環磷醯胺和地塞米松的 → 基礎上加用 daratumumab 與更高的 → 血液學完全緩解頻率和 ✖ 無主要器官惡化或血液學進展的 → 生存率相關。
